Chinese Trial Validates Scleral Lenses
Large Chinese trial confirms strong visual outcomes with four-zone scleral lenses for irregular corneas
Clinical Scorecard: Chinese Trial Validates Scleral Lenses
At a Glance
| Category | Detail |
|---|
| Condition | Irregular Corneas |
| Key Mechanisms | Four-zone scleral lens design for visual rehabilitation |
| Target Population | Chinese adults aged 18–65 with irregular corneas |
| Care Setting | Multi-center clinical trial |
Key Highlights
- 97.7% of participants achieved successful visual rehabilitation at one month
- 98.5% of treated eyes gained two or more lines of vision
- Fitting efficiency with an average of 1.5 lenses per eye
- No serious adverse events reported during the study
- 90% of participants rated comfort and vision highly
Guideline-Based Recommendations
Diagnosis
- Irregular corneas due to keratoconus, secondary ectasia, corneal transplantation, or corneal scarring
Management
- Use of four-zone scleral lenses for visual rehabilitation
Monitoring & Follow-up
- Follow-up for lens fitting and patient-reported outcomes
Risks
- Potential for small changes in corneal curvature and thickness
Patient & Prescribing Data
Adults aged 18–65 with irregular corneas in China
Scleral lenses provide significant visual improvement, especially in advanced corneal disease
Clinical Best Practices
- Consider population-specific anatomical differences in lens fitting
- Monitor patient comfort and lens wear duration
- Ensure proper training in lens application and removal
Related Resources & Content
